Home/Filings/3/0000899243-22-016984
3//SEC Filing

Oxford Science Enterprises plc 3

Accession 0000899243-22-016984

CIK 0001835597other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 8:30 PM ET

Size

11.6 KB

Accession

0000899243-22-016984

Insider Transaction Report

Form 3
Period: 2022-05-05
Holdings
  • Series A-1 Preferred Stock

    Common Stock (1,262,986 underlying)
  • Series B Preferred Stock

    Common Stock (1,547,713 underlying)
  • Series A-2 Preferred Stock

    Common Stock (945,859 underlying)
  • Common Stock

    118,860
Footnotes (2)
  • [F1]The Issuer effected a 1.018-for-1 reverse stock split of its Common Stock on April 29, 2022 ("Reverse Split"). After giving effect to the Reverse Split, the shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock are convertible, at any time, at the holder's election, into shares of the Issuer's common stock at a ratio of 1.018-for-1. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock will automatically convert into shares of the Issuer's common stock at a ratio of 1.018-for-1. The Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock have no expiration date.
  • [F2]This figure reflects the shares of the Issuer's Common Stock underlying the Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock after giving effect to the Reverse Split.

Issuer

PepGen Inc.

CIK 0001835597

Entity typeother
IncorporatedUnited Kingdom

Related Parties

1
  • filerCIK 0001856079

Filing Metadata

Form type
3
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:30 PM ET
Size
11.6 KB